74 related articles for article (PubMed ID: 19194200)
41. Clinical epidemiology of childhood cancer in Central America and Caribbean countries.
Valsecchi MG; Tognoni G; Bonilla M; Moreno N; Baez F; Pacheco C; Hernandez AP; Antillon-Klussmann F; Machin S; Cabanas R; Navarrete M; Nieves R; De Lorenzo P; Masera G;
Ann Oncol; 2004 Apr; 15(4):680-5. PubMed ID: 15033679
[TBL] [Abstract][Full Text] [Related]
42. [Resolutions of the Fourth Central American Venereologic Congress, 12-15 June, 1952, San Jose, Costa Rica].
Rev Med Costa Rica; 1952 Jun; 11(218):111-6. PubMed ID: 13027822
[No Abstract] [Full Text] [Related]
43. [Advances in the gene expression profile analysis and its application in the diagnosis and treatment of childhood acute leukemia].
Guo XP; Tang YM
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):678-81. PubMed ID: 20021791
[No Abstract] [Full Text] [Related]
44. Treatment of acute leukemia of childhood.
HEINLE RW
Ohio State Med J; 1950 Feb; 46(2):133-5. PubMed ID: 15409461
[No Abstract] [Full Text] [Related]
45. Backtracking to the future: unraveling the origins of childhood leukemia.
de Smith AJ; Wiemels JL; Mead AJ; Roberts I; Roy A; Spector LG
Leukemia; 2024 Feb; 38(2):416-419. PubMed ID: 38123697
[No Abstract] [Full Text] [Related]
46. [Preliminary statistical studies on leukemia morbidity in the Krakow Region].
JANICKI K
Pol Arch Med Wewn; 1962; 32():709-15. PubMed ID: 13957345
[No Abstract] [Full Text] [Related]
47. Studies on Childhood Malignancies and Congenitally Determined Leukemia.
Can Med Assoc J; 1961 Jun; 84(22):1261. PubMed ID: 20326774
[No Abstract] [Full Text] [Related]
48. The genetic risk of acute lymphoblastic leukemia and its implications for children of Latin American origin.
de Smith AJ; Jiménez-Morales S; Mejía-Aranguré JM
Front Oncol; 2023; 13():1299355. PubMed ID: 38264740
[TBL] [Abstract][Full Text] [Related]
49. Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes.
Loganathan A; Bharadwaj R; Srinivasan A; Scott JX
South Asian J Cancer; 2022 Oct; 11(4):353-360. PubMed ID: 36756095
[TBL] [Abstract][Full Text] [Related]
50. Cancer health disparities in racial/ethnic minorities in the United States.
Zavala VA; Bracci PM; Carethers JM; Carvajal-Carmona L; Coggins NB; Cruz-Correa MR; Davis M; de Smith AJ; Dutil J; Figueiredo JC; Fox R; Graves KD; Gomez SL; Llera A; Neuhausen SL; Newman L; Nguyen T; Palmer JR; Palmer NR; Pérez-Stable EJ; Piawah S; Rodriquez EJ; Sanabria-Salas MC; Schmit SL; Serrano-Gomez SJ; Stern MC; Weitzel J; Yang JJ; Zabaleta J; Ziv E; Fejerman L
Br J Cancer; 2021 Jan; 124(2):315-332. PubMed ID: 32901135
[TBL] [Abstract][Full Text] [Related]
51. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
[TBL] [Abstract][Full Text] [Related]
52. Global characteristics of childhood acute promyelocytic leukemia.
Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
[TBL] [Abstract][Full Text] [Related]
53. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
Xu H; Cheng C; Devidas M; Pei D; Fan Y; Yang W; Neale G; Scheet P; Burchard EG; Torgerson DG; Eng C; Dean M; Antillon F; Winick NJ; Martin PL; Willman CL; Camitta BM; Reaman GH; Carroll WL; Loh M; Evans WE; Pui CH; Hunger SP; Relling MV; Yang JJ
J Clin Oncol; 2012 Mar; 30(7):751-7. PubMed ID: 22291082
[TBL] [Abstract][Full Text] [Related]
54. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
55. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
56. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
[TBL] [Abstract][Full Text] [Related]
57. Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay.
Dekking E; van der Velden VH; Böttcher S; Brüggemann M; Sonneveld E; Koning-Goedheer A; Boeckx N; Lucio P; Sedek L; Szczepański T; Kalina T; Kovac M; Evans P; Hoogeveen PG; Flores-Montero J; Orfao A; Comans-Bitter WM; Staal FJ; van Dongen JJ;
Best Pract Res Clin Haematol; 2010 Sep; 23(3):333-45. PubMed ID: 21123134
[TBL] [Abstract][Full Text] [Related]
58. Molecular diagnostics in the treatment of leukemia.
Rubnitz JE; Pui CH
Curr Opin Hematol; 1999 Jul; 6(4):229-35. PubMed ID: 10400371
[TBL] [Abstract][Full Text] [Related]
59. Molecular and epidemiologic findings of childhood acute leukemia in Costa Rica.
Santamaría-Quesada C; Vargas M; Venegas P; Calvo M; Obando C; Valverde B; Cartín W; Carrillo JM; Jimenez R; González M
J Pediatr Hematol Oncol; 2009 Feb; 31(2):131-5. PubMed ID: 19194200
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
